跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
immunosuppressant
首页
药物
immunosuppressant
immunosuppressant
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT
EP 4599848 A3
申请人: CARTESIAN THERAPEUTICS INC
优先权: 2017
CN
EP
US
8 件公开
Immunosuppressant compounds and compositions
US 7060697 B2
申请人: IRM LLC
优先权: 2004
CN
US
8 件公开
EP 3138835 A1
申请人: NOVARTIS AG
优先权: 2003
CN
EP
US
6 件公开
EP 2644195 A1
申请人: IRM LLC
优先权: 2003
EP
US
5 件公开
US 2009221547 A1
申请人: IRM LLC
优先权: 2005
CN
US
2 件公开
US 7572811 B2
申请人: IRM LLC
优先权: 2004
US
2 件公开
US 7718704 B2
申请人: IRM LLC
优先权: 2005
US
2 件公开
Immunosuppressant releasing coatings
US 12201421 B2
申请人: MEDTRONIC MINIMED INC
优先权: 2021
CN
EP
US
6 件公开
IMMUNOSUPPRESSANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4174066 A4
申请人: ABBISKO THERAPEUTICS CO LTD
优先权: 2020
CN
EP
US
WO
5 件公开
METHODS FOR DETECTION OF IMMUNOSUPPRESSANT DRUGS
EP 4036572 A1
申请人: SIEMENS HEALTHCARE DIAGNOSTICS INC
优先权: 2007
EP
US
5 件公开
IMMUNOSUPPRESSANT-RESISTANT MODIFIED ALLOGENEIC MODIFIED IMMUNE CELLS AND METHODS FOR USE THEREOF
EP 4683650 A2
申请人: BEAM THERAPEUTICS INC
优先权: 2023
CN
EP
US
WO
4 件公开
Synergistic combinations of macrolide t-cell modulator or immunosuppressant and a retinoid
US 2006100187 A1
申请人: GRASSBERGER MAXIMILIAN
优先权: 2003
CN
US
WO
4 件公开
IMMUNOSUPPRESSANT FORMULATIONS
US 2013273161 A1
申请人: BOUILLOT PHILIPPE MICHEL RENE
优先权: 2011
EP
US
4 件公开
Anti-TIGIT immunosuppressant and application thereof
US 12371491 B2
申请人: BIO THERA SOLUTIONS LTD
优先权: 2019
CN
EP
US
3 件公开
TOPICAL COMPOSITIONS COMPRISING A MACROLIDE IMMUNOSUPPRESSANT
EP 4093396 C0
申请人: BAUSCH HEALTH IRELAND LTD
优先权: 2020
EP
US
WO
3 件公开
第 1 / 9 页
上一页
下一页
药物
反馈